达芬奇机器人手术系统辅助保留迷走神经脾切除联合贲门周围血管离断术的临床疗效

Clinical efficacy of Da Vinci robotic assisted vagus nerve-preserving splenectomy and azygo-portal disconnection

  • 摘要:
    目的 探讨达芬奇机器人手术系统辅助保留迷走神经脾切除联合贲门周围血管离断术的临床疗效。
    方法 采用回顾性描述性研究方法。收集2021年2—5月扬州大学临床医学院收治的10例肝硬化门静脉高压伴食管胃底静脉曲张破裂出血和脾功能亢进病人的临床病理资料;男4例,女6例;中位年龄为55岁,年龄范围为43~64岁。病人均行达芬奇机器人手术系统辅助保留迷走神经脾切除联合贲门周围血管离断术。观察指标:手术施行情况、自体血回输、中转开腹、同种异体输血、手术时间、术中出血量、术后首次进食时间、术后下床活动时间、术后并发症、术后住院时间、随访情况。采用电话、门诊方式进行随访,了解有无消化道再出血、胃潴留。随访时间截至2021年7月。正态分布的计量资料以x±s表示,偏态分布的计量资料以M(范围)表示。计数资料以绝对数表示。
    结果 10例病人均成功施行达芬奇机器人手术系统辅助保留迷走神经脾切除联合贲门周围血管离断术,术中均采用自体血回输技术,无中转开腹,均未行同种异体输血。病人手术时间为(180±14)min、术中出血量为(111±28)mL、术后首次进食时间为(1.5±0.5)d、术后下床活动时间为(2.5±0.7)d。10例病人术后轻度胰液漏1例,肺炎1例,门静脉主干血栓2例,脾静脉血栓3例,均经保守治疗后治愈。10例病人术后住院时间为(8.9±0.9)d,均顺利康复出院,无围手术期死亡病人。10例病人均获得随访,随访时间为3个月(1~4个月),随访期间无消化道再出血、胃潴留发生。
    结论 达芬奇机器人手术系统辅助保留迷走神经脾切除联合贲门周围血管离断术治疗肝硬化门静脉高压伴食管胃底静脉曲张破裂出血和脾功能亢进安全、可行。

     

    Abstract:
    Objective To investigate the clinical efficacy of Da Vinci robotic assisted vagus nerve-preserving splenectomy and azygoportal disconnection.
    Methods The retrospective and descriptive study was conducted. The clinicopathological data of 10 cirrhotic portal hypertension patients with esophagogastric variceal bleeding and hypersplenism who were admitted to Clinical Medical College of Yangzhou University from February to May 2021 were collected. There were 4 males and 6 females, aged from 43 to 64 years, with a median age of 55 years. All 10 patients underwent Da Vinci robotic assisted vagus nerve-preserving splenectomy and azygoportal discon-nection. Observation indicators: surgical situations, intraoperative autologous blood transfusion, conversion to open laparotomy, allogeneic blood transfusion, the operation time, volume of intra-operative blood loss, time to initial diet intake, time for out-of-bed activity, postoperative complica-tion, duration of postoperative hospital stay and follow-up. Follow-up was conducted using out-patient examination and telephone interview to detect recurrent gastrointestinal hemorrhage and gastric retention up to July 2021. Measurement data with normal distribution were represented as Mean±SD and measurement data with skewed distribution were represented as M(range). Count data were described as absolute numbers.
    Results All 10 patients underwent Da Vinci robotic assisted nerve-preserving splenectomy and azygoportal disconnection successfully, with intraopera-tive autologous blood transfusion and without conversion to open laparotomy or allogeneic blood transfusion. The operation time, volume of intraoperative blood loss, time to initial diet intake and time for out-of-bed activity of 10 patients were (180±14)minutes, (111±28)mL, (1.5±0.5)days and (2.5±0.7)days, respectively. Of the 10 patients, 1 case underwent mild pancreatic leakage, 1 case underwent pneumonia, 2 cases underwent portal vein thrombosis and 3 cases underwent splenic vein thrombosis. Patients with postoperative complications was cured after conservative treatment. The duration of postoperative hospital stay of 10 patients was (8.9±0.9)days. All 10 patients were discharged without perioperative death and followed up for 1 to 4 months, with a median follow-up time of 3 months. There was no patient undergoing gastrointestinal hemorrhage and gastric reten-tion.
    Conclusion Da Vinci robotic assisted vagus nerve-preserving splenectomy and azygoportal disconnection is safe and feasible for the treatment of cirrhotic portal hypertension patients with esophagogastric variceal bleeding and hypersplenism.

     

/

返回文章
返回